Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): Demographic features, risk factors, clinical and laboratory profile

Lupus

Volumn 21, Issue 7, 2012, Pages 806-809

  Bertero, M T ^a   Bazzan, M ^b   Carignola, R ^c   Montaruli, B ^d   Silvestro, E ^a   Sciascia, S ^e   Vaccarino, A ^b   Baldovino, S ^e   Roccatello, D ^e  

^a Immunologia Clinica   (Italy)

^b Ematologia e Malattie Trombotiche PO Torino Nord Emergenza S Giovanni Bosco ^*  (Italy)

^c SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^d Patologia Clinica   (Italy)

^e Centro di Ricerche di Immunopatologia e Documentazione Sulle Malattie Rare   (Italy)

Author keywords

antiphospholipid antibodies (aPL); antiphospholipid syndrome (APS)

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CLINICAL FEATURE; CLINICAL PRACTICE; CONFERENCE PAPER; DEMOGRAPHY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HUMAN; ITALY; LABORATORY; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREGNANCY DISORDER; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; VASCULAR DISEASE; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS; THROMBOSIS; YOUNG ADULT;

EID: 84861568408     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312446974     Document Type: Conference Paper

References (8)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002 ; 46: 1019-1027
3. Pierangeli SS, de Groot PG, Dlott J, et al. Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International. Lupus. 2011 ; 20: 182-190
4. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009 ; 7: 1737-1740
5. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum. 1999 ; 42: 1309-1311
6. Garcia-Carrasco M, Galarza C, Gomez-Ponce M, et al. Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients. Lupus. 2007 ; 16: 366-373
7. Pengo V, Ruffatti A, Legnani C, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010 ; 8: 237-242
8. Pengo V, Ruffatti A, Legnani C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibodies profile: a multicenter prospective study. Blood. 2011 ; 118: 4714-4718